Why the study?
The predictive capacity of the systemic immune-inflammation index for detecting new-onset atrial fibrillation following STEMI had not been established.
Does the systemic immune-inflammation index predict new-onset atrial fibrillation following STEMI?
Population
402 STEMI patients
Comparison
Patients with NOAF development vs those without
Key result
A systemic immune-inflammation index cut-off of 1,228,000 predicted new-onset atrial fibrillation following STEMI with 60% sensitivity and 78.1% specificity.
Authors
Loading...
May support SII-guided NOAF risk stratification post-STEMI; extends prior biomarker findings in an RCT population.
Observational (n=402)
Does the systemic immune-inflammation index predict new-onset atrial fibrillation following STEMI?
The systemic immune-inflammation index is an independent predictor of new-onset atrial fibrillation after STEMI, performing similarly to hs-CRP and better than NLR or PLR.
Bağcı et al. (2021) conducted an observational in ST segment elevation myocardial infarction (STEMI) (n=402). Systemic immune-inflammation index (SII) was evaluated on New-onset atrial fibrillation (NOAF). A systemic immune-inflammation index cut-off of 1,228,000 predicted new-onset atrial fibrillation following STEMI with 60% sensitivity and 78.1% specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: